These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 27172295)

  • 81. Combined pulmonary fibrosis and emphysema in alpha-1-antitrypsin deficiency.
    Le Beller A; Nasser M; Traclet J; Blanchet-Legens AS; Kannengiesser C; Mornex JF; Cottin V
    Respir Med Res; 2021 May; 79():100819. PubMed ID: 33862498
    [No Abstract]   [Full Text] [Related]  

  • 82. Validation of markers of lung destruction.
    Burrows B; Bates DV; Cosio MG; DeBerardinis M; Dial S; MacNee W; McLarty JW; Snider GL; Talmadge JE; Weinbaum G
    Ann N Y Acad Sci; 1991 Dec; 624 Suppl():13-21. PubMed ID: 1686161
    [No Abstract]   [Full Text] [Related]  

  • 83. History of the first description of childhood liver disease in AATD.
    Sharp HL
    COPD; 2013 Mar; 10 Suppl 1():13-6. PubMed ID: 23527596
    [TBL] [Abstract][Full Text] [Related]  

  • 84. The Effect of Alpha-1 Proteinase Inhibitor on Biomarkers of Elastin Degradation in Alpha-1 Antitrypsin Deficiency: An Analysis of the RAPID/RAPID Extension Trials.
    Ma S; Lin YY; Cantor JO; Chapman KR; Sandhaus RA; Fries M; Edelman JM; McElvaney G; Turino GM
    Chronic Obstr Pulm Dis; 2016 Nov; 4(1):34-44. PubMed ID: 28848909
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.
    Wanner A; Groft SC; Teagarden JR; Krischer J; Davis BR; Coffey CS; Hickam DH; Teckman J; Nelson DR; McCaleb ML; Loomba R; Strange C; Sandhaus RA; Brantly M; Edelman JM; Farrugia A
    Chronic Obstr Pulm Dis; 2015 Apr; 2(2):177-190. PubMed ID: 28848840
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Alpha-1-antitrypsin deficiency: what next?
    Stockley RA
    Thorax; 2000 Jul; 55(7):614-8. PubMed ID: 10856323
    [No Abstract]   [Full Text] [Related]  

  • 87. Basilar Predominant Emphysema: Thinking beyond Alpha-1-Antitrypsin Deficiency.
    Yeung HM; Gaffaney L
    Case Rep Med; 2022; 2022():9840085. PubMed ID: 36532701
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Statistical considerations in a delayed-start design to demonstrate disease modification effect in neurodegenerative disorders.
    Wang D; Robieson W; Zhao J; Wiener C; Koch G
    Pharm Stat; 2019 Jul; 18(4):407-419. PubMed ID: 30697912
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Editorial: Clinical Trial Design for Alpha-1 Antitrypsin Deficiency: A Model for Rare Diseases.
    Jacobs MR; Criner GJ
    Chronic Obstr Pulm Dis; 2015 Apr; 2(2):91-93. PubMed ID: 28848834
    [No Abstract]   [Full Text] [Related]  

  • 90. Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015.
    Greulich T; Nell C; Herr C; Vogelmeier C; Kotke V; Wiedmann S; Wencker M; Bals R; Koczulla AR
    Orphanet J Rare Dis; 2016 Jun; 11(1):75. PubMed ID: 27282198
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions.
    Hazari YM; Bashir A; Habib M; Bashir S; Habib H; Qasim MA; Shah NN; Haq E; Teckman J; Fazili KM
    Mutat Res Rev Mutat Res; 2017 Jul; 773():14-25. PubMed ID: 28927525
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension.
    Zamanian RT; Weatherald J; Sweatt AJ; Hemnes A; Rashid M; Psotka MA; Bogaard HJ; de Jesus Perez V
    Am J Respir Crit Care Med; 2024 May; 209(10):1189-1195. PubMed ID: 38471030
    [No Abstract]   [Full Text] [Related]  

  • 93. The effect of exacerbations on lung density in α
    Strange C; McElvaney NG; Vogelmeier CF; Marin-Galiano M; Buch-Haensel M; Zhang X; Chen Y; Vit O; Wencker M; Chapman KR
    ERJ Open Res; 2023 Mar; 9(2):. PubMed ID: 36923570
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria.
    van Vollenhoven R; Askanase AD; Bomback AS; Bruce IN; Carroll A; Dall'Era M; Daniels M; Levy RA; Schwarting A; Quasny HA; Urowitz MB; Zhao MH; Furie R
    Lupus Sci Med; 2022 Mar; 9(1):. PubMed ID: 35346982
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Imaging in alpha-1 antitrypsin deficiency: a window into the disease.
    Huang YT; Wencker M; Driehuys B
    Ther Adv Chronic Dis; 2021; 12_suppl():20406223211024523. PubMed ID: 34408834
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Management of lung disease in alpha-1 antitrypsin deficiency: what we do and what we do not know.
    Barjaktarevic I; Campos M
    Ther Adv Chronic Dis; 2021; 12_suppl():20406223211010172. PubMed ID: 34408831
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Small airway evaluation in three subjects with alpha-1 antitrypsin deficiency without diagnosed lung disease.
    Ferrari da Cruz T; Rufino R; Lopes A; Henrique Costa C
    BMJ Case Rep; 2021 Mar; 14(3):. PubMed ID: 33785603
    [TBL] [Abstract][Full Text] [Related]  

  • 98. New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency.
    Chorostowska-Wynimko J; Barrecheguren M; Ferrarotti I; Greulich T; Sandhaus RA; Campos M
    Int J Chron Obstruct Pulmon Dis; 2020; 15():345-355. PubMed ID: 32103933
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Diagnosis and management of α
    Horváth I; Canotilho M; Chlumský J; Chorostowska-Wynimko J; Corda L; Derom E; Ficker JH; Kneussl M; Miravitlles M; Sucena M; Thabut G; Turner AM; van 't Wout E; McElvaney NG
    ERJ Open Res; 2019 Feb; 5(1):. PubMed ID: 30863774
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Intravenous Alpha-1 Antitrypsin Therapy for Alpha-1 Antitrypsin Deficiency: The Current State of the Evidence.
    Brantly ML; Lascano JE; Shahmohammadi A
    Chronic Obstr Pulm Dis; 2018 Nov; 6(1):100-114. PubMed ID: 30775428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.